Stay updated on GeneNews LimitedPress Releases

Sign up to get notified when there's something new on the GeneNews LimitedPress Releases page.
Latest website image capture
Clouds background image

Latest updates to the GeneNews LimitedPress Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    The press-release listing grew from 526 to 529 results. It now includes recent announcements about Sefaxersen data, neuroimmunology trial results, and Genentech’s oncology portfolio, while older releases were removed.
    Difference
    4%
    Check dated 2026-10-25T01:11:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The press release list grows to 526 results with an announcement that Enspryng is the first and only at-home subcutaneous treatment option for thyroid eye disease. A September 17, 2026 release about the Boston R&D Innovation Center opening is no longer listed.
    Difference
    0.8%
    Check dated 2026-10-18T01:04:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The press release listing grew from 523 to 525 results, adding reports on Phase III vamikibart data for uveitic macular edema and FDA approval of Tecentriq with chemotherapy for certain stage III colon cancer. Two older September releases about Lunsumio and Enspryng are no longer listed.
    Difference
    4%
    Check dated 2026-10-11T01:33:58.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The press-release listing now shows 523 results and features newer announcements from late September and October 2026, including updates on cancer treatments, retinal care, multiple sclerosis, and a Hillsboro manufacturing expansion. Several older July and August 2026 releases have dropped off the listing.
    Difference
    6%
    Check dated 2026-10-04T01:38:22.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Two new press releases dated 22 Sep 2026 and 21 Sep 2026 were added to the press releases list, highlighting positive interim data on Sefaxersen and Phase II results for Enicepatide. At the same time, two older items from June 2026 were removed, updating the list to reflect current news coverage.
    Difference
    4%
    Check dated 2026-09-27T01:10:04.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    New press release entries have been added to the listing with dates and headlines, including 17 Sep 2026 Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center; 16 Sep 2026 Genentech’s Lunsumio-Based Regimen Significantly Improves Progression-Free Survival in Follicular Lymphoma in Phase III CELESTIMO Study; and 09 Sep 2026 U.S. FDA Grants Priority Review for Genentech’s Enspryng for MOGAD. Older items have been removed from the listing, such as 10 Jun 2026 FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer; 01 Jun 2026 FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer; and 31 May 2026 Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions.
    Difference
    4%
    Check dated 2026-09-20T00:18:19.000Z thumbnail image

Stay in the know with updates to GeneNews LimitedPress Releases

Enter your email address, and we'll notify you when there's something new on the GeneNews LimitedPress Releases page.